ABSTRACT
Across the world, cardiovascular disease (CVD) is recognized as the prime cause of death due to heart disease and stroke. It is strongly believed that the key challenges in terms of care being faced in CVD across the world are lower availability, accessibility, and affordability of effective and efficient treatment. The problems are also exacerbated by a lack of a focused policy toward noncommunicable diseases (NCDs), including CVDs. Only 13% of the rural population has access to a primary healthcare facility and less than 10% to a hospital. Affordability of quality care is a key concern for most of the population, both for preventive checkups and treatment. In order to address the challenges of low accessibility, affordability, and awareness and meet the healthcare needs of the population, scientists need to innovate low-cost, sensitive, point-of-care devices. Currently, rapid biosensor technology using biomarkers is playing a critical role in the diagnostic revolution of cardiovascular disease with understanding of the issues involved in its initiation, symptoms, and early detection. Apart from POC development, population-wide interventions are needed that can be implemented to reduce CVDs.
